Banque Transatlantique Sa Sangamo Therapeutics, Inc Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
A detailed history of Banque Transatlantique Sa transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Banque Transatlantique Sa holds 2,500 shares of SGMO stock, worth $1,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500Holding current value
$1,175% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SGMO
# of Institutions
136Shares Held
51MCall Options Held
2.17MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.41 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.23 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.21 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.49 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.07 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $73.6M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...